TrueWealth LLC’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

TrueWealth LLC’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$4K	Hold	90	–	–	﹤0.01%	592
2020 Q1	$6K	Hold	90	–	–	﹤0.01%	532
2019 Q4	$11K	Hold	90	–	–	﹤0.01%	452
2019 Q3	$6K	Hold	90	–	–	﹤0.01%	553
2019 Q2	$7K	Hold	90	–	–	﹤0.01%	527
2019 Q1	$10K	Hold	90	–	–	﹤0.01%	461
2018 Q4	$9K	Hold	90	–	–	﹤0.01%	457
2018 Q3	$11K	Hold	90	–	–	0.01%	475
2018 Q2	$8K	Hold	90	–	–	﹤0.01%	541
2018 Q1	$6K	Hold	90	–	–	﹤0.01%	556
2017 Q4	$5K	Buy	+90	New	+$5.68K	﹤0.01%	678

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

TrueWealth LLC's ICPT Position: Q2 2020 in Review

TrueWealth LLC held its Intercept Pharmaceuticals, Inc. (ICPT) position steady in Q2 2020 at 90 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

TrueWealth LLC first reported a position in ICPT in Q4 2017 and has held it in 11 quarters since. The position peaked at $11K in Q4 2019. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

TrueWealth LLC held 90 shares of Intercept Pharmaceuticals, Inc. worth $4K as of Q2 2020.
TrueWealth LLC left its Intercept Pharmaceuticals, Inc. share count unchanged in Q2 2020.
Intercept Pharmaceuticals, Inc. made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #592 holding.
TrueWealth LLC first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and has held it in 11 quarters since.
TrueWealth LLC's Intercept Pharmaceuticals, Inc. position peaked at $11K in Q4 2019.
192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.